BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21955573)

  • 1. Stem cell engraftment and survival in the ischemic heart.
    Wu KH; Mo XM; Han ZC; Zhou B
    Ann Thorac Surg; 2011 Nov; 92(5):1917-25. PubMed ID: 21955573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cell therapy for ischemic heart disease.
    Bonaros N; Rauf R; Schachner T; Laufer G; Kocher A
    Transplantation; 2008 Nov; 86(9):1151-60. PubMed ID: 19005393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment.
    Liu Z; Wang H; Wang Y; Lin Q; Yao A; Cao F; Li D; Zhou J; Duan C; Du Z; Wang Y; Wang C
    Biomaterials; 2012 Apr; 33(11):3093-106. PubMed ID: 22265788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based therapy for ischemic heart disease: a clinical update.
    Herrmann JL; Abarbanell AM; Weil BR; Wang Y; Wang M; Tan J; Meldrum DR
    Ann Thorac Surg; 2009 Nov; 88(5):1714-22. PubMed ID: 19853156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving cell engraftment with tissue engineering.
    Suuronen EJ; Kuraitis D; Ruel M
    Semin Thorac Cardiovasc Surg; 2008; 20(2):110-4. PubMed ID: 18707642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell therapy for ischemic heart disease: where are we?
    LaPar DJ; Kron IL; Yang Z
    Curr Opin Organ Transplant; 2009 Feb; 14(1):79-84. PubMed ID: 19337151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell therapy after myocardial infarction: ready for clinical application?
    Engelmann MG; Franz WM
    Curr Opin Mol Ther; 2006 Oct; 8(5):396-414. PubMed ID: 17078382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-enhancement strategies for the treatment of ischemic heart disease.
    Seeger FH; Zeiher AM; Dimmeler S
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S110-3. PubMed ID: 17230207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research progress of traditional Chinese medicine for stem cell therapy of ischemic heart disease].
    Wu H; Hu Y; Zhou Y; Chu Y
    Zhongguo Zhong Yao Za Zhi; 2009 Apr; 34(8):935-8. PubMed ID: 19639769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of stem cells for the repair of cardiac tissue in ischemic heart disease.
    Brenner C; Franz WM
    Expert Rev Med Devices; 2011 Mar; 8(2):209-25. PubMed ID: 21381911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomaterials to enhance stem cell function in the heart.
    Segers VF; Lee RT
    Circ Res; 2011 Sep; 109(8):910-22. PubMed ID: 21960724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential hazards and technical considerations associated with myocardial cell transplantation protocols for ischemic myocardial syndrome.
    Ben-Dor I; Fuchs S; Kornowski R
    J Am Coll Cardiol; 2006 Oct; 48(8):1519-26. PubMed ID: 17045883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments.
    Templin C; Lüscher TF; Landmesser U
    Int J Dev Biol; 2011; 55(4-5):407-17. PubMed ID: 21553380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell therapy for ischemic heart disease].
    Escobedo-Uribe CD; Monsiváis-Urenda AE; López-Quijano JM; Carrillo-Calvillo J; Leiva-Pons JL; Peña-Duque MA
    Arch Cardiol Mex; 2012; 82(3):218-29. PubMed ID: 23021359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of using autologous mono-nuclears of the bone marrow in treatment of patients with ischemic heart disease].
    Sedov VM; Nemkov AS; Afanas'ev BV; Zverev OG; Nesterko AO; Fregatova LM; Belyĭ SA; Shloĭdo EA; Iudina OV; Ryzhkova DV; Zueva EE; Petrov NV; Stovpiuk OF; Tsurupa SP
    Vestn Khir Im I I Grek; 2006; 165(4):11-4. PubMed ID: 17120413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease.
    Shi RZ; Li QP
    Biochem Biophys Res Commun; 2008 Nov; 376(2):247-50. PubMed ID: 18789897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the survival of engrafted mesenchymal stem cells in the ischemic heart by TNFR gene transfection.
    Bao C; Guo J; Zheng M; Chen Y; Lin G; Hu M
    Biochem Cell Biol; 2010 Aug; 88(4):629-34. PubMed ID: 20651834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury.
    Kofidis T; Lebl DR; Swijnenburg RJ; Greeve JM; Klima U; Robbins RC
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):50-5. PubMed ID: 16337396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-based therapy for chronic ischemic heart disease--a clinical perspective.
    Perin EC; Silva GV
    Cardiovasc Ther; 2011 Jun; 29(3):211-7. PubMed ID: 20955540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts.
    Payne TR; Oshima H; Okada M; Momoi N; Tobita K; Keller BB; Peng H; Huard J
    J Am Coll Cardiol; 2007 Oct; 50(17):1677-84. PubMed ID: 17950150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.